After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
RNA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Avidity Biosciences Inc is $3.68B. A total of 1.38 million shares were traded on the day, compared to an average of 1.21M shares.
In the most recent transaction, Flanagan W. Michael sold 12,742 shares of RNA for 32.66 per share on Dec 18 ’24. After the transaction, the CSTO now owns 72,647 company shares. In a previous transaction on Dec 18 ’24, MacLean Michael F sold 11,151 shares at 32.66 per share. RNA shares that Chief Financial Officer owns now total 82,942.
Among the insiders who sold shares, Boyce Sarah disposed of 31,855 shares on Dec 18 ’24 at a per-share price of $32.66. This resulted in the President and CEO holding 265,308 shares of RNA after the transaction. In another insider transaction, McCarthy Teresa sold 11,151 shares at $32.66 per share on Dec 18 ’24. Company shares held by the Chief Human Resources Officer now total 82,867.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, RNA has a high of $56.00 and a low of $9.93.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. RNA’s latest balance sheet shows that the firm has $405.54M in Cash & Short Term Investments as of fiscal 2021. There were $11.73M in debt and $29.66M in liabilities at the time. Its Book Value Per Share was $12.64, while its Total Shareholder’s Equity was $381.43M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RNA is Buy with a score of 4.83.
